Associate Professor, Pathology, UCSF School of Medicine
Pathology
Dr. Zohreh L. Tabatabai, MD
|
|
Give Review
Zohreh Tabatabai is an expert in the field of Pathology. She researched medicine at University of Missouri-Columbia School of Medicine. Zohreh Tabatabai is a published doctor. She published 35 publications, including: 'Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
- SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.
- Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer.
- Pancreatic neuroendocrine tumors: Accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
- The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma.
- Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.
- The role of metabolic imaging in radiation therapy of prostate cancer.
- Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
- MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer.
- Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer.
- Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival.
- Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
- MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
- Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment.
- DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.
- MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
- Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
- IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.
- Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma.
- Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.
- Wnt antagonist gene polymorphisms and renal cancer.
- The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
- Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.
- Basal cell carcinoma does metastasize.
- Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.
- Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.
- The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.
- The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.
- Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
- Distinguishing primary and metastatic conventional renal cell carcinoma from other malignant neoplasms in fine-needle aspiration biopsy specimens.
- Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
- Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues.
- Radiation-induced atypical glandular cells mimicking recurrent adenocarcinoma in a posthysterectomy vaginal smear.
- Histologic recurrence-free outcome after orthotopic liver transplantation for chronic hepatitis B.
Schools
University Of Missouri Columbia Campus
Doctors Specialties
- Cytopathology
- Pathology
Accepted Insurances
Education
-
University of Texas Health Science Center -
Beth Israel Deaconess Medical Center -
University of Missouri-Columbia School of Medicine
Hospital
-
San Francisco VA Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992763528 |
| Last Name Of The Provider | TABATABAI |
| First Name Of The Provider | ZOHREH |
| View All |
Similar Doctors
|
|
Dr. Frederick L. Baehner, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Abul K. Abbas, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Teresa M. Darragh, MD |
|
|
Dr. Maria M. Patino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore W. Kurtz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Britt-Marie Ljung, MD |
|
|
Dr. Daniel Sudilovsky, MD |
|
|
Dr. Annemieke Van Zante, MD |
|
|
Dr. Sarah M. Calkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Dearmond, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Morvarid Moayeri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher W. Soon, MD
This Doctor is OpenDoctor Recommended.
|